STOCK TITAN

CGEM (NASDAQ: CGEM) insider files to sell 4,000 common shares via Rule 144

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
144

Rhea-AI Filing Summary

Shareholder Jennifer Michaelson has filed a Rule 144 notice to sell up to 4,000 shares of common stock of the company trading under symbol CGEM. The proposed sale is to be executed through Morgan Stanley Smith Barney LLC, with an aggregate market value of $46,400 based on the price used in the notice, and an approximate sale date of January 22, 2026 on the NASDAQ. The filing notes that these 4,000 shares were acquired as restricted stock units from the issuer on December 11, 2023.

The notice also lists recent sales over the past three months for Michaelson’s account, including transactions of 1,345 shares for $13,458.34, 995 shares for $11,840.50, 2,148 shares for $26,592.24, and 4,000 shares for $49,200. Some of these trades are identified as being made under a Rule 10b5-1 trading plan. The filer represents that they are not aware of any undisclosed material adverse information about the issuer’s current or prospective operations.

Positive

  • None.

Negative

  • None.

144: Filer Information

144: Issuer Information

144: Securities Information



Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold


* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.



Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

144: Remarks and Signature

FAQ

How many CGEM shares does Jennifer Michaelson plan to sell under this Rule 144 notice?

The Rule 144 notice states that 4,000 shares of common stock are planned to be sold for the account of Jennifer Michaelson.

What is the estimated market value of the CGEM shares in this Form 144 filing?

The notice reports an aggregate market value of $46,400 for the 4,000 common shares proposed to be sold.

When is the approximate sale date for the CGEM shares in this Rule 144 filing?

The proposed sale date listed in the filing is January 22, 2026.

Which broker is handling the planned CGEM share sale for Jennifer Michaelson?

The filing identifies Morgan Stanley Smith Barney LLC Executive Financial Services, located at One New York Plaza, as the broker for the 4,000-share sale.

How and when did Jennifer Michaelson acquire the CGEM shares covered by this Form 144?

The 4,000 shares covered by the notice were acquired as restricted stock units from the issuer on December 11, 2023, with the payment date shown as the same day.

What prior CGEM stock sales by Jennifer Michaelson are disclosed in the last three months?

The filing lists several recent sales of common stock for Michaelson’s account: 1,345 shares on December 19, 2025 for $13,458.34, 995 shares on December 15, 2025 for $11,840.50, 2,148 shares on December 12, 2025 for $26,592.24, and 4,000 shares on November 24, 2025 for $49,200.00. Several of these trades are labeled as 10b5-1 sales.

What representation does the seller make about inside information in this CGEM Rule 144 filing?

By signing the notice, the person for whose account the securities are to be sold represents that they do not know any material adverse information about the issuer’s current or prospective operations that has not been publicly disclosed.

Cullinan Oncology Inc

NASDAQ:CGEM

CGEM Rankings

CGEM Latest News

CGEM Latest SEC Filings

CGEM Stock Data

685.28M
56.27M
4.54%
107.57%
10.57%
Biotechnology
Biological Products, (no Disgnostic Substances)
Link
United States
CAMBRIDGE